1. Tavassoli FA, Devilee P, editors. World Health Organization: tumours of the breast and female genital organs. 2003. Lyon: IARC press;297–301.
2. Scully RE, Barlow JF. "Mesonephroma" of ovary. Tumor of Müllerian nature related to the endometrioid carcinoma. Cancer. 1967. 20:1405–1417.
Article
3. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med. 1971. 284:878–881.
Article
4. Hanselaar A, van Loosbroek M, Schuurbiers O, Helmerhorst T, Bulten J, Bernhelm J. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks. Cancer. 1997. 79:2229–2236.
10. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol Oncol. 2000. 78:97–105.
11. Goto K, Takeuchi Y, Yakihara A, Kotsuji F. Synchronous invasive squamous cell carcinoma and clear cell adenocarcinoma of the uterine cervix: a different human papillomavirus status. Gynecol Oncol. 2005. 97:976–979.
Article
12. Pirog EC, Kleter B, Olgac S, Bobkiewicz P, Lindeman J, Quint WG, et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma. Am J Pathol. 2000. 157:1055–1062.
Article
13. Reich O, Tamussino K, Lahousen M, Pickel H, Haas J, Winter R. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol. 2000. 76:331–335.
Article
14. Boyd J, Takahashi H, Waggoner SE, Jones LA, Hajek RA, Wharton JT, et al. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer. 1996. 77:507–513.
Article
15. Waggoner SE, Baunoch DA, Anderson SA, Leigh F, Zagaja VG. Bcl-2 protein expression associated with resistance to apoptosis in clear cell adenocarcinomas of the vagina and cervix expressing wild-type p53. Ann Surg Oncol. 1998. 5:544–547.
Article
16. Herbst AL. Diethylstilbestrol and adenocarcinoma of the vagina. Am J Obstet Gynecol. 1999. 181:1576–1578.
Article
17. Okamoto Y, Hirota S, Soejima T, Maeda H, Takada Y, Hasegawa K, et al. Radiotherapy for adenocarcinoma of the uterine cervix. Nippon Igaku Hoshasen Gakkai Zasshi. 1997. 57:936–941.
18. Thomas MB, Wright JD, Leiser AL, Chi DS, Mutch DG, Podratz KC, et al. Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era. Gynecol Oncol. 2008. 109:335–339.
Article
19. Stehman FB, Rose PG, Greer BE, Roy M, Plante M, Penalver M, et al. Innovations in the treatment of invasive cervical cancer. Cancer. 2003. 98:2052–2063.
Article
20. Kwack HS, Mun YJ, Ha JE, Hwang SJ, Kim SM, Han KT, et al. Fertility-sparing radical abdominal trachelectomy for cervical clear cell adenocarcinoma unrelated to diethylstilbestrol exposure: a case report. Korean J Obstet Gynecol. 2009. 52:960–965.